Raymond James & Associates »

Cognition Therapeutics shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Cognition Therapeutics (CGTX) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Cognition Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cognition Therapeutics held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cognition Therapeutics by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $18k 10k 1.82

More positions owned by Raymond James & Associates

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Ishares Tr Core Msci Eafe (IEFA)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Home Depot (HD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Msci Usa Min Vol (USMV)
Merck & Co (MRK)
Eaton Corp SHS (ETN)

View all positions for Raymond James & Associates

Top funds holding Cognition Therapeutics

AIGH Capital Management
Vanguard Group
AWM Investment Company
Alyeska Investment Group
Timelo Investment Management
Corsair Capital Management
Hohimer Wealth Management
Kestra Advisory Services
American Financial Group
Geode Capital Management
CM Management
Sigma Planning
Commonwealth Equity Services
Bridgeway Capital Management
Mercer Global Advisors

View all funds holding Cognition Therapeutics